Ligusticum wallichii-rhizoma atractylodis pill for treating depression syndrome
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 赖婷婷
- Publication Date
- 2017-05-31
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to Xiongzhu pills for treating depression syndrome. Background technique
[0002] Depression syndrome is caused by emotional discomfort and qi stagnation, with depression, restlessness, fullness in the chest, distending pain in the chest and hypochondrium, or irritability and easy crying, or obstruction by foreign objects in the pharynx, etc. A type of syndrome manifested. According to the clinical manifestations of depression syndrome and its characteristics of emotional internal injury as the cause of the disease, it is mainly seen in neurasthenia, hysteria and anxiety in Western medicine.
[0003] At present, Western medicine mainly uses NSAIDs and immunosuppressants such as Anle Tablets, Clomipramine Hydrochloride Tablets, and Paroxetine Hydrochloride Tablets. Though these medicines have effect, side effect is big, easily cause the corresponding pathological changes of other organs of human body. Adopting traditional Chines...